All books in Book Publisher International are published under the Open Access model. No subscription, registration, or access fees are required. Readers are allowed to read, download, copy, distribute, print, search, and link to the full-text versions of all chapters.
Book Publisher International’s Authorship Policy is based on ICMJE criteria for authorship. Submission of a book chapter or monograph to Book Publisher International indicates that the author(s) have agreed on the content of the manuscript. One author should be indicated as the corresponding author for all publication related communications. The author(s) should substantially contribute to the design of the work; or the analysis, or interpretation of data for the work. The author(s) must participate in drafting or revising the work and approve the final version to be published. All correspondence and proofs would be sent to the corresponding author, who will be treated as a final representative voice for all authors regarding any decision related to the manuscript unless otherwise requested during submission.
Book Publisher International would not be responsible for any dispute related to authorship of a submitted monograph or book chapter. Any change in the authorship (such as addition or deletion of the author(s) or change in the sequence of author list) should be intimated to the editorial office through a letter signed by all authors before publication of the book. In absence of any signed letter, approval of final version (ready-to-be-published) by the corresponding author will work as the ‘certificate of final agreement of authorship’. Generally, any change in the authorship after final publication is not entertained and COPE guidelines are followed for any dispute.
Peer Review Policies and Review Process Flow:
Book Publisher International aims to publish high-quality research work. All submitted book chapters or monographs are subject to peer review before publication. To know about Book Publisher International’s Peer Review Policies and Review Process Flow, kindly click here.
Book Publisher International strongly opposes the practice of duplicate publication or any type of plagiarism. Once submitted, all the manuscripts will be screened for plagiarism checking. Book Publisher International uses plagiarism checking software, which checks content uploaded by the Editorial office against a database of periodicals, the Internet, and a comprehensive database and generates a Similarity Report. If plagiarism is found in any monograph or book chapter after an internal investigation, a letter would be immediately sent to all the authors, their affiliated institutes and funding agency, if applied and subsequently the manuscript will be rejected.
Standard Protocol on Approvals, Registrations, Patient Consents & Animal Protection:
All clinical investigations must be conducted according to the Declaration of Helsinki principles. Regarding the patient’s consent for research or participation in a study, authors must comply with the guidelines of the International Committee of Medical Journal Editors (www.icmje.org). Patients’ details like names, initials (including figures), or hospital numbers must not be mentioned anywhere in the manuscript. Academic Editor may request the authors to provide documentation of the formal review and recommendation from the Institutional Review Board or Ethics Committee responsible for oversight of the study.
Book Publisher International’s Copyright Policy aims to guarantee that original material is published while at the same time giving significant freedom to the authors. The copyrights of all published monographs or book chapters are retained by the respective authors as per the ‘Creative Commons Attribution License’ (http://creativecommons.org/licenses/by/4.0/). Monographs are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license granted to all authors. The author(s) should be the sole author(s) of the article and should have full authority to enter into the agreement and in granting rights (if any) to Book Publisher International, which are not in breach of any other obligation. Authors should mandatorily ensure that submission of the book chapter to Book Publisher International would result in no breach of contract or of confidence or of commitment given to secrecy.
Book Publisher International is passionate about working with the global academic community to promote best scholarly research in the world. Book Publisher International normally follows the guidelines given in COPE website. The authors, academic editors, the reviewers, and the Societies (if applicable) are also requested to strictly follow this excellent guideline. For human or animal experimental investigations, a formal review and approval, or review and waiver, by an appropriate Institutional Review Board or Ethics Committee should be provided. This should be documented in the manuscript clearly. For human investigations, the way of informed consent collection from the study participants (i.e., oral or written) should be mentioned in the Methods section. Authors should obtain patient consent in the case of the confidential case history. In the case of briefcase vignettes which do not contain identifying information or if the case material is disguised adequately to prevent identification of the patient, consent is not necessary. The author(s) should inform the purpose of publication, the possible risks and benefits to the patient and the patient’s right to withhold or withdraw the consent. In the case of a minor patient, consent should be obtained from the parent(s) or guardian(s) of the patient(s).
Conflicts of Interest Policy:
Book Publisher International is determined to promote integrity in research publication. All the authors, the academic editors, and the reviewers are required to transparently declare all possible conflicts of interest in line with publication ethics practices recommended by COPE, ICMJE, and other similar organizations. Financial contributions to the work should be clearly acknowledged, as should any potential conflict of interest.
Correction and Retraction Policy:
To know about Book Publisher International’s Correction and Retraction Policy, click here.
To know about Book Publisher International’s representative guideline for Authorship Dispute, kindly click here.
Book Publisher International’s Correction and Retraction Policy is developed in accordance with COPE’s publication guidelines pertaining to scientific misconduct, any publication disputes, authorship disputes, and research ethics. For these kinds of disputes, we generally visit and follow the COPE website and author(s) are also requested to do so. The publisher is determined to act upon any reports of scientific misconduct in its published work and accordingly will make an effort to start an investigation of such claims. In case of retraction or removal of the work, the publisher will be under no obligation to refund the paid amount.
Advertising is currently not permitted in any of Book Publisher International’s publications.
Refunds are possible if double payment has been made by the author by mistake. Refunds will also be made in rare cases if Book Publisher International does not publish the book. In some instances author(s) request to withdraw the accepted document prior to publication. Refunds of 50% of the paid amount may be issued if Book Publisher International, based on its own judgment, determines that the withdrawal is fully justified. Refunded amounts will not always be the same as originally paid amounts due to payment gateway charges, money conversion charges or bank transaction fees or other expense if any. In case of retraction or removal of the Work, the publisher will be under no obligation to refund the paid amount.
High-quality, bound/unbound, print/e-reprints can be purchased for all published books, book chapters and monographs.
Appeals and Complaints
Author(s) who wish to make a complaint or appeal should refer it to the Academic Editor of the edited volume or monograph concerned or the publisher directly to firstname.lastname@example.org
Book Publisher International, its staff or members of the editorial board will not bear any responsibility for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by Book Publisher International.
click to edit text
click to edit text
If you have an unresolved privacy or data use concern that we have not addressed satisfactorily, please contact our Editorial Office directly at email@example.com.
As per the principle of BPI, we never sell, rent, or otherwise provide your personal data to anybody. We try to provide all possible cyber-security (possible by us) to protect all the information of the users. But the reality is that no website is 100% hacking proof. Therefore, BPI will not be responsible for any loss/theft of data, personal information, email ID, password, etc. and any kind of subsequent losses arising from these hacking, theft etc. Users are strongly advised to set the password as strong as possible by using a combination of alpha-numeric-special characters. Users are also strongly requested to use the password (for BPI account) separate from the passwords of their credit card, bank, email ID, etc.
1. ABOUT BOOK PUBLISHER INTERNATIONAL:
Book Publisher International (a part of SCIENCEDOMAIN International) is an international publishing organization that publishes textbooks, atlases, monographs, e-books, edited volumes and reference books in scientific, technical, and medical areas. The Registered Office addresses are available here (http://www.bookpi.org/contact-us).
2. DATA COLLECTION:
Authors, Editors and other users can browse and view BPI website without providing any personal information. Registering in the BPI website and uploading bio-data, telephone number, email ID, etc. are completely optional and voluntary. Third parties are not allowed to see users’ personal information, unless they are publicly available as part of the publishing activities or approved by the users or are required by law to do so. We use your information to:
Allow Authors to access the information they need in order to publish their work
Allow BPI to send service email notifications or promotional messages about new publications released
Administer your account and customize the service we provide to you and other users
Provide your personal details to third parties offering combined services with BPI, enabling you to share your information and communicate with other users
3. FOR THE ABOVE-MENTIONED PURPOSES WE MAY COLLECT THE FOLLOWING INFORMATION:
The first name, Last name, academic/job title, Organization/Institution and previous publications.
Contact information in the form of email address, postal address, country of residence.
Other information regarding your scientific field of interest, education and work experience.
4. COLLECTION OF ADDITIONAL INFORMATION:
5. USERS’ RIGHTS:
Authors, Coauthors, Editors and Coeditors can choose what information you make available to other registered and unregistered users. You are free to change your personal information at any time except your login e-mail address. BPI will provide you with information about whether we hold any of your personal information. If the personal information changes, you may correct, update or delete it by making the change on your user panel, or by contacting us by email.
You are welcome to submit a request to close your BPI account at any time. If you no longer need our services, or you want to deactivate your account, you can contact us by email at firstname.lastname@example.org. We will respond to your request within a reasonable timeframe.
6. OPEN ACCESS:
Publication of an article in Book Publisher International is intrinsically an open process. Immediately after publication of a manuscript, the name, surname, affiliation and email address of the corresponding author will be available to website users with the sole purpose to facilitate scientific communication. Collecting these email addresses for commercial use is strictly prohibited.
7. THIRD PARTIES:
BPI does not sell, rent, or otherwise provide your personal information to third parties unless we have your permission or are required by law so as to comply with a legal process. Please note that in order to deliver certain services (for example, Chapter publication), we may share information with third parties. To process payments made by you, we share some of your information with the payment gateway company we use. While you are entitled to decline to provide the information requested, this may prevent us from providing the services requested. In the case of delivery of hard copies of books to authors or other parties ordering such publications, we share with third parties conducting postal delivery services the information required in order to carry out the delivery. These companies are authorized to use your personal information only as necessary to provide these services to us. If BPI is involved in a merger, acquisition, or sale of all or a portion of its assets, you will be notified via email.
8. EMAIL POLICY:
If users have previously agreed to receive email/newsletter services using the personal information for, BPI may contact registered members from time to time to let them know information that may be of interest. You may opt out from receiving such email when registering as a member, or at any time thereafter by responding to such an email or contacting customer services. Additionally, users can also unsubscribe by clicking the ‘Unsubscribe’ button in all our marketing emails.
9. CHANGES IN THE POLICY:
10. LEGAL RESPONSIBILITIES:
We reserve the authority to disclose members’ personal information if required to do so by law, or in the belief that such action is logically necessary to comply with legal process, respond to claims, or protect the rights, property or safety of BPI, employees or members.
11. CONTACT US:
For any queries or questions about your privacy and Book Publisher International please contact our editorial office at email@example.com
This policy is effective from 2018-12-28.
click to edit text
click to edit text
AUTHORSHIP DISPUTE POLICY
Policy for Authorship before Publication:
Any change in the authorship (such as addition or deletion of the author(s) or change in the sequence of author list) should be intimated to the editorial office through a letter signed by all authors before publication of the book. In absence of any signed letter, approval of final version (ready-to-be-published) by the corresponding author will work as ‘final agreement of authorship’.
Policy for Authorship after Publication:
Generally, any change in the authorship after final publication is not entertained. But if dispute resolution is absolutely necessary then below-mentioned policies and COPE guidelines are followed.
Kindly follow these representative guideline steps and for more information visit our website and COPE site.
1. Each existing author (as published in the book or book chapter or monograph), should explain in details the reasons for the change in authorship. Each existing author should write separately this letter in the present University letterhead, sign and clearly scan the letters and send us to the publisher’s official mail ID (firstname.lastname@example.org) from their official mail ID. In order to prove that these are their official emails, each author should send soft copy of their own published paper, where these email IDs are printed or send us the link of their official homepage in their University website, where these emails IDs are available or any certificate from HOD about authenticity of this email ID.
2. Each new author should write to the publisher that what contribution he/she has made to this book chapter or monograph and why he/she wants to establish and get his/her authorship. Each new author should write separately this letter in the present University letterhead, sign and clearly scan the letters and send us to the publisher’s official mail ID (email@example.com) from their official mail ID. In order to prove that these are their official emails, each author should send soft copy of their own published paper, where these email IDs are printed or send us the link of their official homepage in their University website, where these emails IDs are available or any certificate from HOD about authenticity of this email ID.
3. The corresponding author should write to us that what contribution new author(s) has made to this book chapter or monograph and why existing authors should be excluded. The corresponding author should also explain that why he/she has approved the final version with disputed authors, which is normally considered as a certificate of agreement of authorship, as per the publisher’s rule. The corresponding author should write separately this letter in the present University letterhead and sign and clearly scan the letters and send us to the publisher’s official mail ID (firstname.lastname@example.org) from his/her official mail ID. In order to prove that this is his/her official mail, corresponding author should send soft copy of his/her own published paper, where these email IDs are printed or send us the link of his/her official homepage in their University website, where this email ID is available or any certificate from HOD about authenticity of this email ID.
4.If the editorial office receives written signed consent from all existing and new authors, as explained above, then “Final Authorship” will be changed and published.
If we don’t get written signed consent from all existing and new authors, as explained above, then the following steps (5&6) will be followed.
5. The corresponding author should send the complete mailing address and email IDs (of each existing and new author’s) of their respective 1. Head of the department 2. Vice-Chancellor/Director/Rector of the University (with webpage link).
6. The editorial office will officially request the topmost authority of each university to investigate this case of “Authorship dispute”. Depending on the investigation result of each respective University and their recommendation, “Final authorship” will be decided and will be changed accordingly in the book chapter or the monograph.
Book Publisher International would not be responsible for any dispute related to the authorship of a submitted/published book or book chapter or monograph.
All the documents (as per the editorial policy of Book Publisher International) should reach to editorial office to initiate any action.
click to edit text
click to edit text
Book Publisher International aims to cover all major disciplines including science, medicine, technology, humanities and social sciences. The publication is a joint effort between the author(s) and the publisher. Author(s) are encouraged to concentrate on the scientific content only. The publisher will guide and take care of the layout and other formalities.
Book Publisher International publishes authored and edited Book, short Monograph, long Monograph, Book Chapter as a part of Edited Volume, Book series, Textbooks, Handbooks, etc. The Author Guidelines, presented here are based on standardized book writing norms and are fully approved by the Book Publisher International. Author(s) and Editor(s) should endeavour to follow these guidelines carefully before submitting the manuscript to the publisher.
Interested Author(s)/Editor(s) may submit the proposal using the BPI Proposal Form for any of the following types of Books. All submissions for proposals or manuscripts as well as any queries or suggestions should be addressed to the Managing Editor at email@example.com.
Types of Books
Authored Book: It is written by the single author or multiple authors. There is no page limit for a Book.
Book Chapter: It is written by the single author or multiple authors and published as a part of an Edited Volume. The word limit is up to 12000 words. The work may be an original research on a particular subject or a specific aspect of that subject.
Edited Volume: It is a collection of book chapters written by multiple authors and edited by one or more editors on a particular subject or a specific aspect of that subject.
Long Monograph: It is a writing up to 200000 words written by one or more authors. The work may be an original research on a particular subject or a specific aspect of that subject.
Short monograph: Same as a Long monograph with a word limit up to 25000 words.
Book Series: It is the publication of a number of Books in a series of Volumes on a particular subject or a specific aspect of that subject. Each volume is edited by a minimum of one or more editors. The Authored book series volume may contain many chapters contributed by the same authors. The Edited book series volume may contain several chapters contributed by different authors, solicited by the Editor(s). At the same time, the editor(s) may also write some chapter(s). The publishing contract signed between Author(s)/Editor(s) and the publisher will initially be valid for three volumes and may be renewed by mutual consent for future volume(s).
Once the peer-review is complete and the Work is accepted for publication by the Editor, the Editor/Author will need to sign a publishing contract for their book with Book Publisher International.
Main Guidelines for the Author(s)
1. Originality: Submission of a manuscript entails that the work has not been published previously nor is under consideration for publication elsewhere. Submission of any content to Book Publisher International will automatically transfer all rights for publication, selling and distribution in all forms of media (electronic and printed, etc.) to Book Publisher International. It is the responsibility of the person submitting the contents to have the prior written consent of the organization/person where/by whom the work was carried out.
2. English Style: The manuscript must be written in British or American English in a clear and active style to maintain the uniformity throughout the text. Authors from non-English speaking countries should team up with English speaking colleagues or contact with professional English editing companies for checking the language, style and grammar of the manuscript. Alternatively, for English language and grammatical corrections, editors/authors are advised to contact International Research Promotion (www.researchpromotion.com) to avail copyediting and language editing services (firstname.lastname@example.org), our contracted publishing services company.
3. Content Organization: The manuscript may be divided into the following sections:
Authors and Institutional Affiliations
Table of contents
Greek Symbols and Special Characters
Equations and Mathematical ExPublisherions
List of Abbreviations
Conflict of Interest
4. Files: The complete manuscript must be provided in the form of a single zipped folder containing soft copies of all the materials i.e., main text in MSWORD or Tex/Latex format, figures/illustrations, tables, equations and chemical structures, as separate files. A PDF version of the manuscript embedded with all the figures/illustrations/tables/chemical structures etc. in the correct location must also be submitted.
5. Numbering Style: Author(s) are requested to select the numbering style for the chapters and apply this style consistently to all chapters or sections.
6. Tables & figures should be placed inside the text. Tables and figures should be presented as per their appearance in the text. It is suggested that the discussion about the tables and figures should appear in the text before the appearance of the respective tables and figures. No tables or figures should be given without discussion or reference inside the text.
Tables should be explanatory enough to be understandable without any text reference. Double spacing should be maintained throughout the table, including table headings and footnotes. Table headings should be placed above the table. Footnotes should be placed below the table with superscript lowercase letters.
Each figure should have a caption. The caption should be concise and typed separately, not on the figure area. Figures should be self-explanatory. Information presented in the figure should not be repeated in the table. All symbols and abbreviations used in the illustrations should be defined clearly. Figure legends should be given below the figures.
7. Abbreviations, special characters, etc: Before submission, author(s) should carefully proofread the manuscript for abbreviations, special characters, mathematical symbols, Greek letters, equations, tables, figures, references and images, to ensure that they appear in proper order and format.
8. Nomenclature and Units
Internationally accepted rules and the international system of units (SI) should be used. If other units are mentioned, please give their equivalent in SI.
For biological nomenclature, the conventions of the International Code of Botanical Nomenclature, the International Code of Nomenclature of Bacteria, and the International Code of Zoological Nomenclature should be followed.
Scientific names of all biological creatures (crops, plants, insects, birds, mammals, etc.) should be mentioned in parentheses at first use of their English term.
9. Chemical nomenclature, as laid down in the International Union of Pure and Applied Chemistry and the official recommendations of the IUPAC-IUB Combined Commission on Biochemical Nomenclature should be followed. All biocides and other organic compounds must be identified by their Geneva names when first used in the text. Active ingredients of all formulations should be likewise identified.
10. Math formulae
All equations referred to in the text should be numbered serially at the right-hand side in parentheses. Meaning of all symbols should be given immediately after the equation at first use. Instead of root signs, fractional powers should be used.
Subscripts and superscripts should be presented clearly. Variables should be presented in italics. Greek letters and non-Roman symbols should be described in the margin at their first use.
To avoid any misunderstanding zero (0) and the letter O, and one (1) and the letter l should be clearly differentiated.
For simple fractions use of the solidus (/) instead of a horizontal line is recommended.
Levels of statistical significance such as: *P <0.05, **P <0.01 and ***P <0.001 do not require any further explanation.
Guideline for Reporting P values: P is always italicized and capitalized.
ii) The P value should be exPublishered to 2 digits whether or not it is significant. If P < .01, it should be exPublishered to 3 digits.
iii) When rounding, 3 digits is acceptable if rounding would change the significance of a value (eg, P = .049 rounded to .05).
iv) ExPublishering P to more than 3 significant digits does not add useful information since precise P values with extreme results are sensitive to biases or departures from the statistical model.
v) Reporting actual P values avoids this problem of interpretation. P values should not be listed as not significant (NS) since, for meta-analysis, the actual values are important and not providing exact P values is a form of incomplete reporting.
vi) Do not use 0 before the decimal point for statistical values P, alpha, and beta because they cannot equal 1.
A brief acknowledgement section may be given. The acknowledgements of people who provided assistance in manuscript preparation, funding for research, etc. should be listed in this section. All sources of funding should be declared as an acknowledgement. Authors should declare the role of the funding agency, if any, in the study design, collection, analysis and interpretation of data; in the writing of the manuscript. If the study sponsors had no such involvement, the authors should so state.
12. Competing Interests
Declaration of competing interest is compulsory. All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If no such declaration has been made by the authors, Book Publisher International reserves to assume and write this sentence: “Authors have declared that no competing interests exist.”
13. List of Contributors
Names of all contributors to the book, in alphabetical order with their affiliations and addresses, are published in this page.
14. Patient Consents
All clinical investigations must be conducted according to the Declaration of Helsinki principles. No manuscript will be peer-reviewed if a statement of patient consent is not presented during submission (wherever applicable). This section is compulsory for medical Works. It should provide a statement to confirm that the patient has given the informed consent for the research work to be published. Editorial office may ask the copies of the consent documentation at any time. If the person described in the research work has died, then consent for publication must be collected from their next of kin. If the individual described in the article is a minor, or unable to provide consent, then consent must be sought from their parents or legal guardians.
15. Ethical approval (Wherever applicable)
This section is compulsory for medical research works. If human subjects are involved, informed consent, protection of privacy, and other human rights are further criteria against which the manuscript will be judged. It should provide a statement to confirm that the authors have obtained all necessary ethical approval from suitable Institutional or State or National or International Committee. This confirms either that this study is not against the public interest, or that the release of information is allowed by legislation.
All manuscripts which deal with animal subjects must be approved by an Institutional Review Board (IRB), Ethical Committee, or an Animal Utilization Study Committee and this statement, and approval number must accompany the submission. If required, the author should be ready to submit a scanned copy of the IRB or Ethical Committee Approval at any stage of publication (Pre or post-publication stage). The manuscript should contain information about any post-operative care and pain management for the animals.
All manuscripts which deal with the study of human subjects must be accompanied by Institutional Review Board (IRB) or Ethical Committee Approval, or the national or regional equivalent. The name of the Board or Committee giving approval and the study number assigned must accompany the submission. If required, the author should be ready to submit a scanned copy of the IRB or Ethical Committee Approval at any stage of publication (Pre or post-publication stage).
16. Reference style
References must be listed at the end of the manuscript and numbered in the order that they appear in the text. Every reference referred to in the text must also present in the reference list and vice versa. In the text, citations should be indicated by the reference number in brackets .
Only published or accepted manuscripts should be included in the reference list. Articles submitted for publication, unpublished findings and personal communications should not be included in the reference list but may be mentioned in the text (e.g., T Nelson, Purdue University, USA, Unpublished results or personal communication). Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, obtain written permission and confirmation of accuracy from the source of a personal communication. An unpublished result which has been accepted for publication in any journal should be cited as “in Publisher”. Journal name abbreviations should be those found in the NCBI databases (Link: http://www.ncbi.nlm.nih.gov/nlmcatalog/journals).
All references should follow the following style:
Reference to a journal:
For Published paper:
1. Hilly M, Adams ML, Nelson SC. A study of digit fusion in the mouse embryo. Clin Exp Allergy. 2002;32(4):489-98.
Note: List the first six authors followed by et al.
Note: Use of DOI number for the full-text article is encouraged. (if available).
Note: Authors are also encouraged to add other database’s unique identifier (like PUBMED ID).
For Accepted, unpublished papers.
Same as above, but “In Publisher” appears instead of the page numbers.
1. Saha M, Adams ML, Nelson SC. Review of digit fusion in the mouse embryo. J Embryol Exp Morphol. 2009;49(3): (In Publisher).
Note: List the first six authors followed by et al.
Note: Use of DOI number is encouraged (if available).
Note: Authors are also encouraged to add other database’s unique identifier (like PUBMED ID).
For Articles not in English
Forneau E, Bovet D. Recherches sur l’action sympathicolytique d’un nouveau dérivé du dioxane. Arch Int Pharmacodyn. 1933;46:178-91. French.
Reference to a book:
Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. Edinburgh: Churchill Livingstone; 2003.
Editor(s) or compiler(s) as authors
Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, editors. The Merck manual of diagnosis and therapy. 18th ed. Whitehouse Station (NJ): Merck Research Laboratories; 2006.
Authored chapter in the edited publication
Glennon RA, Dukat M. Serotonin receptors and drugs affecting serotonergic neurotransmission. In: Williams DA, Lemke TL, editors. Foye’s principles of medicinal chemistry. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.
Reference to Web-resource or Electronic articles.
Hugo JT, Mondal SC. Parallels between tissue repair and embryo morphogenesis: a conceptual framework. Global Health. 2006;16:4. Accessed 29 March 2012. Available: http://www.globalizationandhealth.com/content/1/1/14.
Anonymous. Parallels between tissue repair and embryo morphogenesis: a conceptual framework. Global Health. 2006;16:4. Accessed 29 March 2012. Available: http://www.globalizationandhealth.com/content/1/1/14.
Reference to Organization as an author
Diabetes Prevention Program Research Group. A study of digit fusion in the mouse embryo. J Embryol Exp Morphol. 2009;49(2):259–276.
17. Back Cover Page
A brief write-up (100-150 words) on the major contributions and current affiliation of the author and the Editor will be printed on the back cover page of the print version along with his/her photograph. Author and the Editor need to submit this information.